Advisor

Chang Zou

Precision-medicine advisor

Background

Chang Zou holds a doctorate in biomedical sciences from The Chinese University of Hong Kong and a bachelor’s degree in clinical medicine from Southeast University in Nanjing.

He is deputy director of the Clinical Medical Research Centre at Shenzhen People’s Hospital and a visiting associate professor at the School of Medicine, The Chinese University of Hong Kong, Shenzhen. He supervises postgraduate students at several medical universities and leads a research group in precision oncology.

He was named a Guangdong Outstanding Young Medical Talent in 2019. His laboratory works on how solid tumours are matched to individualised drug regimens — the subject matter this site writes about.

In short

Title
Associate Chief Technologist; Deputy Director, Clinical Medical Research Centre
Institution
Shenzhen People's HospitalSchool of Medicine, The Chinese University of Hong Kong, Shenzhen
Areas of expertise
  • Tumour epigenetics and the mechanisms of drug resistance
  • Single-cell and spatial transcriptomics of the tumour microenvironment
  • Clinical translation of liquid biopsy
  • Individualised drug selection for solid tumours

What this advisor does — and does not do

The advisor gives an opinion on how precision-oncology topics are framed on this site: which mechanisms are described correctly, where clinical guidance is silent, and where a term is used loosely. That is a consultation role, and it is different from reviewing every article before publication.

  • He advises on the scientific framing of our precision-oncology content.
  • He does not review every article, and does not vouch for the accuracy of any individual page.
  • He does not provide care to patients through this site. Nothing here is medical advice, and no doctor–patient relationship is created.

Relationship disclosure

Shenzhen People’s Hospital, where the advisor works, is one of the partner hospitals listed on this site. We disclose that relationship here so that readers can weigh it.